Measuring adherence and persistence to disease-modifying agents among patients with relapsing remitting multiple sclerosis

Medication adherence and persistence among patients with relapsing remitting MS is far from monolithic. Measuring medication adherence and persistence among defined populations is useful for understanding the relationship between medication use and outcomes in practice and for targeting patients and programs to improve medication adherence.